K S Tveit

Long‐term efficacy and safety of biosimilar infliximab (CT‐P13) after switching from originator infliximab: open‐label extension of the NOR‐SWITCH trial

Guro Løvik Goll, Kristin Kaasen Jørgensen, J. Sexton et al. · Journal of Internal Medicine · 2019 · 116 citations · Full text

Randomized phase III study of 5-fluorouracil/folinate/oxaliplatin given continuously or intermittently with or without cetuximab, as first-line treatment of metastatic colorectal cancer: The NORDIC VII study (NCT00145314), by the Nordic Colorectal Cancer Biomodulation Group.

K S Tveit, Tormod Kyrre Guren, Bengt Glimelius et al. · Journal of Clinical Oncology · 2011 · 73 citations

Braf Mutation, Gastrointestinal Oncology, Medicine +15

Quality of life and contact with healthcare systems among patients with psoriasis and psoriatic arthritis: results from the NORdic PAtient survey of Psoriasis and Psoriatic arthritis (NORPAPP)

Albert Duvetorp, Mikkel Østergaard, Lone Skov et al. · Archives of Dermatological Research · 2019 · 42 citations · Full text

Quality Of Life, Life Assessment, Dermatology +20

Treatment use and satisfaction among patients with psoriasis and psoriatic arthritis: results from the NORdic PAtient survey of Psoriasis and Psoriatic arthritis (NORPAPP)

K S Tveit, Albert Duvetorp, Mikkel Østergaard et al. · Journal of the European Academy of Dermatology and Venereology · 2018 · 27 citations · Full text

A Randomized, Double-blind, Placebo-controlled Clinical Study to Investigate the efficacy of Herring Roe Oil for treatment of Psoriasis

K S Tveit, Karl A. Brokstad, Rolf K. Berge et al. · Acta Dermato Venereologica · 2020 · 17 citations · Full text